{"database": "lobbying", "table": "lobbying_activities", "rows": [[2299323, "4381a4fd-1205-413d-80b1-f7e321e75e5c", "Q2", "CAMERON COMPANIES", 401095057, "FOX CHASE CANCER CENTER", 2019, "second_quarter", "MMM", "The President's FY 2020 Budget as it relates to site neutral payment policies and funding for the National Institutes of Health, monitored the introduction of drug pricing legislation for its potential impact on existing and emerging cancer drug therapies.  Monitored Medicare reimbursement developments in the agencies and Congress for alternative cancer therapies such as CAR-T.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2019-07-03T14:13:12.180000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2299323"], "units": {}, "query_ms": 0.2964260056614876, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}